Avoid high-fat foods: Minimizing fatty food intake can decrease the severity of diarrhea
Body Protection Compound
For those with insurance but still facing high out-of-pocket costs, the PAN Foundation offers a co-pay assistance program that helps eligible patients with type 2 diabetes afford their ongoing Ozempic treatment
Mild itchiness at the injection site is a common side effect that can last for a day or two
Funding This work was funded by two grants from the Deanship of Scientific Research and Graduate Studies, Applied Science Private University, Amman, Jordan (DRGS/2024/11), and Princess Nourah bint Abdulrahman University Researchers Supporting Project Number (PNURSP2026R305), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
The advent of incretin-based therapies and the expansion to multi-receptor agonist peptides targeting glucagon-like peptide 1 (GLP1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin receptors has transformed obesity treatment, demonstrating average weight loss of more than 20% in humans and improvements in a broad range of obesity-related comorbidities
